Castle Biosciences, Inc. Common Stock
CSTL Real Time Price USDRecent trades of CSTL by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by CSTL's directors and management
Government lobbying spending instances
-
$40,000 Oct 03, 2024 Issue: Medicare/Medicaid
-
$40,000 Jul 09, 2024 Issue: Medicare/Medicaid
-
$60,000 Apr 01, 2024 Issue: Medicare/Medicaid
-
$60,000 Jan 05, 2024 Issue: Medicare/Medicaid
-
$30,000 Oct 06, 2023 Issue: Medicare/Medicaid
Estimated quarterly lobbying spending
New patents grants
-
Patent Title: Methods of diagnosing and treating patients with cutaneous squamous cell carcinoma May. 07, 2024
-
Patent Title: Methods of diagnosing and treating patients with cutaneous squamous cell carcinoma May. 07, 2024
-
Patent Title: Diagnostic test for predicting metastasis and recurrence in cutaneous melanoma Sep. 06, 2022
-
Patent Title: Diagnostic test for predicting metastasis and recurrence in cutaneous melanoma Mar. 03, 2020
Federal grants, loans, and purchases
- $20,000 2024-10-01 00:00:00 Agency: Department of Veterans Affairs
- $14,450 2023-06-30 00:00:00 Agency: Department of Veterans Affairs
- $12,500 2023-06-20 00:00:00 Agency: Department of Veterans Affairs
- $125,000 2022-09-07 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $14,450 2022-05-17 00:00:00 Agency: None
- $0 2021-08-10 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $36,550 2021-07-01 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $37,400 2020-05-06 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
Estimated quarterly amount awarded from public contracts
Number of mentions of CSTL in WallStreetBets Daily Discussion
Recent insights relating to CSTL
Recent picks made for CSTL stock on CNBC
ETFs with the largest estimated holdings in CSTL
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view CSTL Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.